z-logo
open-access-imgOpen Access
Genome Sequence Comparison of Staphylococcus aureus TX0117 and a Beta-Lactamase-Cured Derivative Shows Increased Cationic Peptide Resistance Accompanying Mutations in relA and mnaA
Author(s) -
Mia Jade Sales,
George Sakoulas,
Richard Szubin,
Bernhard Ø. Palsson,
César A. Arias,
Kavindra V. Singh,
Barbara E. Murray,
Jonathan M. Monk
Publication year - 2020
Publication title -
microbiology resource announcements
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.383
H-Index - 35
ISSN - 2576-098X
DOI - 10.1128/mra.01515-19
Subject(s) - staphylococcus aureus , whole genome sequencing , microbiology and biotechnology , cefazolin , biology , peptide , antimicrobial , plasmid , strain (injury) , genome , bacteria , beta (programming language) , genetics , gene , antibiotics , biochemistry , anatomy , computer science , programming language
Staphylococcus aureus strain TX0117 is a methicillin-susceptible bacterium with type A beta-lactamase exhibiting a high cefazolin inoculum effect. TX0117 was cured of blaZ , yielding TX0117c with increased antimicrobial peptide resistance. The sequencing and genome assembly of TX0117 elucidate six mutations between TX0117 and TX0117c, including relA truncation and mnA_1 substitution.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom